| Page 15 | Aplastic Anemia and MDS International Foundation

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes

Author(s): 
Gerds AT, Woo Ahn K, Hu ZH, Abdel-Azim H, Akpek G, Aljurf M, Ballen KK, Beitinjaneh A, Bacher U, Cahn JY, Chhabra S, Cutler C, Daly A, DeFilipp Z, Gale RP, Gergis U, Grunwald MR, Hale GA, Hamilton BK, Jagasia M, Kamble RT, Kindwall-Keller T, Nishihori T
Primary Author: 
Gerds AT
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Mar 2017

For patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation, umbilical cord blood transplantation (UCBT) has become an acceptable alternative donor source in the absence of a matched sibling or unrelated donor.

Bone Marrow Diseases: 

Myelodysplastic Syndromes and Iron Chelation Therapy

Author(s): 
Angelucci E, Urru SA, Pilo F, Piperno A
Primary Author: 
Angelucci E
Journal Title: 
Mediterr J Hematol Infect Dis
Original Publication Date: 
Mar 2017

Over recent decades we have been fortunate to witness the advent of new technologies and of an expanded knowledge and application of chelation therapies to the benefit of patients with

Bone Marrow Diseases: 

Solving Emma’s Diagnostic Mystery

Person's Name: 
Emma

In January 2016, my 9 year-old daughter Emma turned yellow. After seeing her regular doctor, we were sent straight to the hospital. They found that her liver enzymes were extremely elevated and sent us to a second hospital. After extensive blood panels and scans, they still couldn’t determine the cause of Emma’s liver inflammation, and so the process to find her a new liver began.

Bone Marrow Diseases: 

Tartan Trailblazers March for Marrow: Detroit, Michigan

Get up, get out and get going to the Tartan Trailblazers March for Marrow 5K Run & Walk! Whether you’re a jock or not, you can turn out and help us find a cure for

Event Date: 
Sun, 06/04/2017 -
11:00am to 3:30pm
Community Event Type: 

Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes.

Author(s): 
Diamantopoulos P, Zervakis K, Zervakis P, Sofotasiou M, Vassilakopoulos T, Kotsianidis I, Symeonidis A, Pappa V, Galanopoulos A, Solomou E, Kodandreopoulou E, Papadopoulou V, Korkolopoulou P, Mantzourani M, Kyriakakis G, Viniou NA
Primary Author: 
Diamantopoulos P
Journal Title: 
Blood Cancer J
Original Publication Date: 
Feb 2017

Poly (ADP-ribose) polymerase 1 (PARP-1) has a central role in the repair of DNA breaks and is a promising treatment target in malignancy. We measured PARP1 mRNA levels by a SYBR-green-based PCR in the

Bone Marrow Diseases: 

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.

Author(s): 
Woo J, Howard NP, Storer BE, Fang M, Yeung CC, Scott BL, Deeg HJ
Primary Author: 
Woo J
Journal Title: 
Haematologica
Original Publication Date: 
Feb 2017

No abstract available.

Bone Marrow Diseases: